Ad-hoc Announcements 2011

Here you find Ad-hoc messages of year 2011.

To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.

September 29, 2011

Phase III Study of Bayer’s Rivaroxaban in Patients with Acute Coronary Syndrome Meets Primary Efficacy Endpoint

Download PDF collect (87 KB)


September 6, 2011

Bayer AG: FDA has published documents for discussion at the Advisory Committee on the new drug application for Rivaroxaban

Download PDF collect (124 KB)


Investor News issued in year 2011 can be found here.

Publications of the previous years are offered in the Archive Overview.